Charles S. Grob, M.D., is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center. He conducted the first government-approved study of MDMA, and was the principal investigator of an international biomedical psychiatric research project in the Brazilian Amazon of the plant, ayahuasca. He is currently conducting an investigation of the effects of psilocybin on anxiety in cancer patients. Dr. Grob has published numerous articles in medical and psychiatric journals and collected volumes, and is the editor of Hallucinogens: A Reader. He is a founding board member of the Heffter Research Institute.
above extract is from the program notes for the
The talk presented here was given by Dr. Grob, and one of the participants in his current cancer anxiety study, during July 2005 at a salon in the L.A. area. Now in their seventh year, Kathleen's monthly evening of intellectual excitement has become a meeting place for some of the most influential and fascinating minds on the West Coast.
Dr. Grob recently co-edited, with Roger Walsh, "Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics", SUNY Press (State University of New York press), 2005. [Read a review by Lorenzo]
Pam and Norbert, research pioneers, in front of a painting by psychedelic elder, Gary Fisher.
Dr. Grob speaking at Kathleen's salon
Psychedelic pioneer Myron Stolaroff and Marycie listen to Dr. Grob and Pam talk about the psilocybin study being conducted at the Harbor-UCLA Medical Center. Marycie is Dr. Grob's research nurse for study being discussed.